Patient P-02544
Synthetic patientMETA-24 · Day 176 · 55–64 · F · baseline S12Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
27%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S12
- Day 15 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 15.
Primary contributors, last 14 days
- Toxicity-17
- GI instability+10
- Nutritional resilience-3
- Treatment adherence-3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable61 min
stable · -0.4 vs previous 14 d
Sleep duration
Wearable5.6 h
stable · -0.2 vs previous 14 d
Energy level
Daily log5/10
improving · +0.2 vs previous 14 d
Steps
Wearable7,435
stable · -51 vs previous 14 d
GI burden
Companion25.2/100
stable · -0.0 vs previous 14 d
Adherence
Companion92.5 %
stable · +1.9 vs previous 14 d
Sleep quality
Wearable27.5/100
stable · -0.2 vs previous 14 d
Glucose, CGM daily mean
CGM141 mg/dL
stable · +3.5 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 68 from the failing basin, 22 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -5.8 next day on high-intake days · n 24
- More histamineGI -4.3 next day on high-intake days · n 14
Would not help
- Keep caffeine lowGI +5.8 next day on high-intake days · n 21
- Keep ultra-processed lowGI +5.2 next day on high-intake days · n 22
- Keep simple carbs lowGI +4.8 next day on high-intake days · n 20
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Caffeine+5.8detractor · 95%
- Protein-5.8supporter · 95%
- Ultra-processed food+5.2detractor · 95%
- Simple carbohydrates+4.8detractor · 95%
- Histamine load-4.3supporter · 95%
- Alcohol-1.7no signal · 33%
- Insoluble fibre+1.1no signal · 22%
- Dietary fat load+0.5no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↓45
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Autonomic recovery ↑20
- WearableShort sleep window
- Mucosal barrier integrity ↓10
- WearableSleep 5.6 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Poor metabolizerHigher exposure at standard dose
Microbiome
Shannon diversity 2.9 · butyrate capacity 68/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 48 ms
- Sleep
- 5.8 h
- Steps
- 8,171
- Resting HR
- 69 bpm
Daily log: GI score 25, nutritional resilience 62, adherence 93.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02462 | 55% | S12 | DT-01 | improved | 65 |
| P-02620 | 45% | S01 | HY-01 | improved | 64 |
| P-02518 | 44% | S17 | DT-01 | improved | 68 |
| P-02538 | 44% | S02 | GI-04 | improved | 59 |
| P-02082 | 43% | S12 | NP-02 | improved | 53 |
| P-02235 | 43% | S14 | DT-01 | improved | 50 |
| P-02645 | 42% | S02 | HY-01 | improved | 56 |
| P-02033 | 41% | S06 | GI-04 | improved | 51 |
| P-02037 | 40% | S04 | GI-04 | improved | 53 |
| P-02147 | 40% | S13 | GI-04 | improved | 58 |
| P-02274 | 40% | S15 | DT-01 | improved | 50 |
| P-02339 | 40% | S03 | DT-01 | improved | 50 |